FTC Grants Early Termination Of HSR Waiting Period For Allergan-Tobira Deal
DUBLIN (dpa-AFX) - Allergan plc (AGN) and Tobira Therapeutics, Inc.
(TBRA) said that the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, with respect to Allergan's pending acquisition of Tobira. Both companies expect the transaction to be completed by the end of 2016.
Tobira is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for non-alcoholic steatohepatitis or NASH and other liver diseases.
Copyright RTT News/dpa-AFX